AIG
LUMO

American International Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

American International Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,062
Closed -$36K – 3165
2019
Q1 		$36K Sell
2,062
-67
-3% -$999 ﹤0.01% 2942
2018
Q4 		$29K Sell
2,129
-17
-0.8% -$299 ﹤0.01% 2987
2018
Q3 		$46K Buy
2,146
+39
+2% +$1.19K ﹤0.01% 3076
2018
Q2 		$90K Buy
2,107
+45
+2% +$2.06K ﹤0.01% 2840
2018
Q1 		$135K Sell
2,062
-111
-5% -$7.87K ﹤0.01% 2491
2017
Q4 		$159K Buy
2,173
+542
+33% +$44.8K ﹤0.01% 2458
2017
Q3 		$149K Buy
1,631
+122
+8% +$9.36K ﹤0.01% 2449
2017
Q2 		$100K Buy
1,509
+29
+2% +$3.59K ﹤0.01% 2726
2017
Q1 		$321K Buy
1,480
+98
+7% +$14K ﹤0.01% 1892
2016
Q4 		$128K Sell
1,382
-4
-0.3% -$451 ﹤0.01% 2459
2016
Q3 		$187K Buy
1,386
+2
+0.1% +$199 ﹤0.01% 2211
2016
Q2 		$140K Buy
1,384
+19
+1% +$2.35K ﹤0.01% 2384
2016
Q1 		$224K Hold
1,365
– – ﹤0.01% 2684
2015
Q4 		$447K Sell
1,365
-2
-0.1% -$651 ﹤0.01% 2128
2015
Q3 		$441K Buy
1,367
+2
+0.1% +$879 ﹤0.01% 2122
2015
Q2 		$544K Sell
1,365
-30
-2% -$12.7K ﹤0.01% 2101
2015
Q1 		$687K Hold
1,395
– – ﹤0.01% 1910
2014
Q4 		$499K Sell
1,395
-110
-7% -$32.7K ﹤0.01% 2144
2014
Q3 		$290K Buy
1,505
+66
+5% +$14.5K ﹤0.01% 2613
2014
Q2 		$344K Buy
1,439
+163
+13% +$33.1K ﹤0.01% 2505
2014
Q1 		$326K Buy
1,276
+31
+2% +$9.48K ﹤0.01% 2409
2013
Q4 		$247K Sell
1,245
-13
-1% -$2.31K ﹤0.01% 2602
2013
Q3 		$213K Buy
1,258
+61
+5% +$9.82K ﹤0.01% 2679
2013
Q2 		$212K Buy
+1,197
New +$170K ﹤0.01% 2520

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

American International Group's LUMO Position: Q2 2019 in Review

American International Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 2,062 shares — an estimated $36K sold.

American International Group first reported a position in LUMO in Q2 2013 and held it in 24 quarters. The position peaked at $687K in Q1 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

  • American International Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 2,062 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $36K.
  • American International Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • American International Group's Lumos Pharma, Inc. Common Stock position peaked at $687K in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.